Literature DB >> 23876223

Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011.

P Kieny1, S Chollet, P Delalande, M Le Fort, A Magot, Y Pereon, B Perrouin Verbe.   

Abstract

OBJECTIVES: Retrospective study over the last 30 years of life expectancy in patients suffering from Duchenne muscular dystrophy (DMD). Analysis of the role of ventilatory assistance and causes of death. PATIENTS AND METHODS: One hundred and nineteen adult DMD patients were hosted during 1981 to 2011 at AFM Yolaine de Kepper centre, Saint-Georges-sur-Loire, France. Patients' life expectancy was calculated using Kaplan-Meier model.
RESULTS: Life expectancy without or with ventilatory assistance was 22.16 and 36.23 years, respectively. Similarly, life expectancy of patients born from 1970 (mostly with ventilatory assistance) was 40.95 years old from 1970 and 25.77 years old before 1970. Causes of death changed. Cardiac origins of death have increased from 8% to 44%.
CONCLUSION: Ventilator assistance, in this study mostly through tracheotomy prolongs by more than 15 years life expectancy of DMD patients. It allows conservation of a satisfactory quality of life, and should be systematically proposed to patients.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Assistance ventilatoire; Duchenne muscular dystrophy; Dystrophie musculaire de Duchenne; Espérance de vie; Survival; Tracheotomy; Trachéotomie; Ventilatory assistance

Mesh:

Year:  2013        PMID: 23876223     DOI: 10.1016/j.rehab.2013.06.002

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  53 in total

1.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Sean C Forbes; Sunita Mathur; Sean A Germain; Claudia R Senesac; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-04-13       Impact factor: 4.296

2.  Social/economic costs and health-related quality of life in patients with rare diseases in Europe.

Authors:  Julio López-Bastida; Juan Oliva-Moreno; Renata Linertová; Pedro Serrano-Aguilar
Journal:  Eur J Health Econ       Date:  2016-03-29

3.  Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy.

Authors:  Carol A Wittlieb-Weber; Kenneth R Knecht; Chet R Villa; Chentel Cunningham; Jennifer Conway; Matthew J Bock; Katheryn E Gambetta; Ashwin K Lal; Kurt R Schumacher; Sabrina P Law; Shriprasad R Deshpande; Shawn C West; Joshua M Friedland-Little; Irene D Lytrivi; Michael A McCulloch; Ryan J Butts; David R Weber; Jonathan N Johnson
Journal:  Pediatr Cardiol       Date:  2020-02-03       Impact factor: 1.655

Review 4.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

5.  Current treatment and management of dystrophinopathies.

Authors:  Nathalie Goemans; Gunnar Buyse
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

6.  Deficit in PINK1/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy.

Authors:  Chifei Kang; Myriam A Badr; Viktoriia Kyrychenko; Eeva-Liisa Eskelinen; Natalia Shirokova
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

7.  Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy.

Authors:  Eric Himelman; Mauricio A Lillo; Julie Nouet; J Patrick Gonzalez; Qingshi Zhao; Lai-Hua Xie; Hong Li; Tong Liu; Xander Ht Wehrens; Paul D Lampe; Glenn I Fishman; Natalia Shirokova; Jorge E Contreras; Diego Fraidenraich
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 8.  Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.

Authors:  Qing Ke; Zheng-Yan Zhao; Robert Griggs; Veronica Wiley; Anne Connolly; Jennifer Kwon; Ming Qi; Daniel Sheehan; Emma Ciafaloni; R Rodney Howell; Petra Furu; Peter Sazani; Arvind Narayana; Michele Gatheridge
Journal:  World J Pediatr       Date:  2017-05-17       Impact factor: 2.764

9.  Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.

Authors:  Bin Xu; Alessandro Magli; Yoska Anugrah; Steven J Koester; Rita C R Perlingeiro; Wei Shen
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

10.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.